BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 27567526)

  • 1. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
    Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
    Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
    Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
    Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
    Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
    PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
    Hulse M; Caruso LB; Madzo J; Tan Y; Johnson S; Tempera I
    PLoS Pathog; 2018 Nov; 14(11):e1007394. PubMed ID: 30395643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMP1 strain variants: biological and molecular properties.
    Mainou BA; Raab-Traub N
    J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1.
    Sung WW; Chen PR; Liao MH; Lee JW
    Exp Cell Res; 2017 Oct; 359(1):94-100. PubMed ID: 28827059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY; Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
    Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
    Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
    J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
    Sun J; Hu C; Zhu Y; Sun R; Fang Y; Fan Y; Xu F
    PLoS One; 2015; 10(8):e0134896. PubMed ID: 26244812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.